Related Experiment Video

Updated: Jul 5, 2026

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

PPAR Ligands for Cancer Chemoprevention

Yumiko Yasui1, Mihye Kim, Takuji Tanaka

  • 1Department of Oncologic Pathology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293, Japan.

PPAR Research
|May 17, 2008
PubMed

Insights

Peroxisome proliferators-activated receptors (PPARs) are nuclear receptors that regulate cell processes. PPAR ligands show promise in cancer prevention and treatment by modulating carcinogenesis.

Area of Science:

  • Molecular biology
  • Oncology
  • Pharmacology

Background:

  • Peroxisome proliferators-activated receptors (PPARs) are nuclear receptors involved in tumor progression, differentiation, and apoptosis.
  • PPAR isoforms (PPARα, PPARδ, PPARγ) regulate gene expression upon ligand binding.
  • PPAR activation exhibits both anticarcinogenic and anti-inflammatory effects.

Purpose of the Study:

  • To review the current data on the role of PPAR ligands in carcinogenesis.
  • To highlight the potential of PPAR signaling in cancer prevention and treatment.

Main Methods:

  • Literature review of studies investigating PPAR ligands and their effects on cancer.
  • Analysis of in vitro and in vivo data regarding PPAR signaling in carcinogenesis.

Main Results:

  • Numerous PPAR ligands, both synthetic and natural, have been identified.
  • PPAR ligands activate PPAR signaling pathways, demonstrating anticancer effects.
  • The specific effects are dependent on the PPAR isoform and ligand type.

Conclusions:

  • PPAR ligands represent a promising therapeutic strategy for cancer control.
  • Further research into PPAR modulators could lead to novel cancer therapies.
  • Understanding PPAR isoform-specific activities is crucial for targeted cancer treatments.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...